Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,161.2
-5.7 (-0.18%)

 

  • STI Straits Times Index
    3,161.2
    -5.7 (-0.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,493.0
    -1.6 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,235.8
    274.8 (1.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,464.3
    66.9 (1.97%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,781.0
    497.4 (1.82%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,096.5
    26.5 (0.44%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,145.9M
  • Value: 1,099.4M
  • Rise: 166
  • Fall: 177
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.116+0.001
Rex Intl0.235+0.025
Abundance Intl0.046+0.004
Raffles Edu0.080-0.020
Genting Sing0.805-0.005
Mercurius0.057-0.004
KTL Global^0.122+0.004
YZJ Shipbldg SGD1.390+0.020
ISDN0.810+0.045
ThaiBev0.645-0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,672.7 -105.6
HSI 26,235.8 +274.8
HSCEI 9,336.6 +103.4
Jakarta 6,096.5 +26.5
Nikkei 225 27,781.0 +497.4
SSE Comp 3,464.3 +66.9
Shanghai A 3,630.9 +70.2
Shanghai B 257.6 +3.6
KOSPI 3,223.0 +20.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

UGHealthcare UG HEALTHCARE CORPORATIONLTD
Quotes 10 Minutes Delayed. Updated at 02 Aug 2021 17:10
Last (SGD): 0.550 Change: -0.015 High: 0.565 Remarks: -
Change (%): -2.66 Low: 0.550
Open 0.565 Yesterday's Close 0.565
Buy Price 0.550 Sell Price 0.560
Buy Volume ('000) 245.8 Sell Volume ('000) 10.0
Cumulative Volume ('000) 1,308.7 Cumulative Value 730,928
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.02175 Trailing EPS (SGD) e 0.10952 NAV (SGD) b 0.2061
PE a 25.287 Trailing PE f 5.022 Price / NAV b 2.6686
Dividend (SGD) d , k 0.002272 Cash In Hand (SGD) g 0.0702 Issued & Paid-up Shares c 616,259,000
Dividend Yield (%) d , k 0.413 Price / Cash In Hand g 7.835 Treasury Shares h -
Beta - 75 Daysi -0.250 R-Squared - 75 Days(%)i 0.54 Market Cap (M) 338.942
Beta - 500 Daysi 0.004 R-Squared - 500 Days (%)i - Enterprise Value (M) 315.237
Piotroski F Score 7 Exchange Code 8K7 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 62.1371 6-Month VWAP 0.672 Free Float (%) 17.8
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.
  10. Adjusted based on Full Year Jun 2020: Annual Dividend of SG 0.7140 cents declared was based on pre-split shares. Final Dividend to be paid has been revised from SG 0.7140 cents to SG 0.2380 cents per post-split share.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference UGHealthcare SGX 338.942 25.287 5.022 2.6686 0.413
Industry Medical & Biotechnology SGX 971.029 20.311 19.271 1.3966 1.993
Medical Specialties SGX 1,832.353 14.126 3.644 4.1807 3.196
Index FTSE ST Catalist Index SGX 65.688 109.341 51.095 1.5570 1.636
Local Peer Top Glove SGX 10,085.809 16.612 3.613 4.5868 3.105
Local Peer Medtecs Intl SGX 437.129 2.510 2.510 1.7090 8.434
Local Peer Biolidics SGX 69.018 - - 8.3333 -
Local Peer Yunnan Energy SGX 46.549 - - 1.2612 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer ABBOTT LABORATORIES NYSE 214,959.684 48.057 33.847 - 1.261
Global Peer DANAHER CORP NYSE 212,378.111 60.507 60.507 5.3783 0.241
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 212,239.050 33.292 24.690 5.7589 0.164
Global Peer MEDTRONIC PLC NYSE 176,467.509 48.937 48.937 3.4314 1.769
Global Peer INTUITIVE SURGICAL INC NASDAQ 117,733.892 111.007 72.559 10.8636 -
Global Peer STRYKER CORP NYSE 102,170.390 63.896 49.050 7.3929 0.867
Global Peer BECTON DICKINSON & CO NYSE 74,376.959 96.971 45.352 2.9962 1.232
Global Peer EDWARDS LIFESCIENCES CORP NYSE 69,791.186 84.760 71.735 - -
Global Peer BOSTON SCIENTIFIC CORP NYSE 64,793.496 - 138.448 - -
Global Peer IDEXX LABORATORIES INC NASDAQ 57,865.513 99.463 85.828 82.3479 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), RESMED INC (NYSE), BAXTER INTERNATIONAL INC (NYSE), ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), NOVOCURE LTD (NASDAQ), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), MICROPORT-100 (HKEx), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ANGELALIGN (HKEx), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), ENVISTA HOLDINGS CORPORATION (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), QUIDEL CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), HARTA (Bursa), NEVRO CORP (NYSE), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), EBOS GROUP (ASX), CARDIOFLOW-B (HKEx), NUVASIVE INC (NASDAQ), HAEMONETICS CORP (NYSE), AXONICS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), VENUS MEDTECH-B (HKEx), PEIJIA-B (HKEx), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), GLAUKOS CORPORATION (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), LIFETECH SCI (HKEx), ZYLOXTB-B (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), SUPERMX (Bursa), BIOLIFE SOLUTIONS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), INOGEN INC (NASDAQ), KANGJI MEDICAL (HKEx), BUTTERFLY NETWORK INC (NYSE), LANTHEUS HOLDINGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), EARGO INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), AK MEDICAL (HKEx), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), NANOSONICS LIMITED (ASX), LEMAITRE VASCULAR INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), VIEWRAY INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CRYOLIFE INC (NYSE), ANGIODYNAMICS INC (NASDAQ), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CHUNLI MEDICAL (HKEx), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), BIOVENTUS INC (NASDAQ), CERUS CORP (NASDAQ), 908 DEVICES INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), AXOGEN INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), MODERN DENTAL (HKEx), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), KDL MEDICAL (HKEx), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), BASECARE-B (HKEx), PAVMED INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), SIENTRA INC (NASDAQ), SOLITON INC (NASDAQ), ONCOCYTE CORP (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), IRADIMED CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), LUCIRA HEALTH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CVRX INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), NEURONETICS INC (NASDAQ), YESTAR HEALTH (HKEx), CYTOSORBENTS CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), INVACARE CORP (NYSE), DARIOHEALTH CORP (NASDAQ), CORMEDIX INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), INTRICOM CORP (NASDAQ), TELA BIO INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), TITAN MEDICAL INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), ALPHA PRO TECH (NYSE American), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), CHECK-CAP LTD (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), MICRO-X LTD (ASX), IRIDEX CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), OPTISCAN IMAGING (ASX), AVINGER INC (NASDAQ), LENSAR INC (NASDAQ), BIOLASE INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), NEUROMETRIX INC (NASDAQ), NEPHROS INC (NASDAQ), KELFRED (HKEx), ZOSANO PHARMA CORP (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), EKSO BIONICS HOLDINGS INC (NASDAQ), ADVENTA (Bursa), YUNNAN ENERGY (HKEx), SENSUS HEALTHCARE INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), NEOVASC INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), RGTBHD (Bursa), HANCOCK JAFFE LABORATORIES INC (NASDAQ), COMPUMEDICS (ASX), CARDIEX LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), LKL (Bursa), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), ADHERIUM LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), METALICITY LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE American), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.025
-4.35 %
10 Days --0.055
-9.09 %
20 Days --0.010
-1.79 %
Medium Term Return 3 Months --0.175
-24.14 %
6 Months 0.001-0.189
-25.44 %
1 Year 0.003-0.418
-42.87 %
Long Term Return 2 Years 0.006+0.492
+858.62 %
3 Years 0.008+0.477
+664.38 %
5 Years 0.014+0.457
+506.45 %
Annualised Return Annualised --
+43.40 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.524 - 1.145 Change From 1 Year Low +0.026 % Change From 1 Year Low (%) +4.94
Change From 1 Year High -0.595 % Change From 1 Year High (%) -51.95
2 Years Range 0.044 - 1.145 Change From 2 Years Low +0.506 % Change From 2 Years Low (%) +1161.47
Change From 2 Years High -0.595 % Change From 2 Years High (%) -51.95
5 Years Range 0.044 - 1.145 Change From 5 Years Low +0.506 % Change From 5 Years Low (%) +1161.47
Change From 5 Years High -0.595 % Change From 5 Years High (%) -51.95
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

UG Healthcare Corporation Limited manufactures and distributes natural latex and nitrile examination gloves. It markets its natural latex and nitrile examination gloves under the Unigloves brand name, as well as under third party labels. The company also distributes ancillary products, such as surgical, vinyl, and cleanroom gloves, as well as face masks and other medical disposables. Its gloves are used in healthcare, food and beverage, and automotive industries. The company markets its products in approximately 50 countries, including Germany, Nigeria, the People's Republic of China, the United States, the United Kingdom, France, Italy, Austria, Switzerland, the Netherlands, Japan, South Korea, Canada, and Brazil. UG Healthcare Corporation Limited was founded in 1989 and is based in Seremban, Malaysia.

IPO Performance

Listing Date 08 Dec 2014 Full Subscription Rate (x) 11.51
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 1.80 Public Offer Subscription Rate (x) 169.08
IPO Price (SGD) a 0.072 First Day Close (SGD) a 0.083 First Week Close (SGD) a 0.077
Current vs IPO Price (%) +663.89 First Day Gain (%) +15.28 First Week Gain (%) +6.94
Notes:
  1. Adjusted for the following: Share Split 3 for 1 on 30/09/2020, Special Dividend S$0.00105 on 2/3/2021

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Jun 2020 Part 1(3.07 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
02 Aug 2021 0.565 0.565 0.550 0.550 1,308,700 0.5585
30 Jul 2021 0.565 0.575 0.560 0.565 1,283,700 0.5664
29 Jul 2021 0.560 0.570 0.560 0.565 461,700 0.5625
28 Jul 2021 0.560 0.570 0.555 0.560 1,707,200 0.5608
27 Jul 2021 0.580 0.580 0.560 0.560 2,269,400 0.5664
26 Jul 2021 0.605 0.605 0.575 0.575 2,178,900 0.5844
23 Jul 2021 0.605 0.615 0.600 0.605 1,216,600 0.6062
22 Jul 2021 0.615 0.615 0.600 0.605 1,029,900 0.6073
21 Jul 2021 0.615 0.620 0.600 0.620 3,685,000 0.6125
19 Jul 2021 0.600 0.620 0.595 0.605 3,379,100 0.6073
16 Jul 2021 0.590 0.605 0.580 0.590 4,136,700 0.5959
15 Jul 2021 0.550 0.590 0.550 0.590 6,436,900 0.5763
14 Jul 2021 0.555 0.555 0.545 0.550 535,900 0.5504
13 Jul 2021 0.560 0.560 0.550 0.555 1,224,600 0.5530
12 Jul 2021 0.575 0.575 0.555 0.560 1,324,300 0.5636
09 Jul 2021 0.545 0.570 0.545 0.565 3,248,100 0.5619
08 Jul 2021 0.565 0.565 0.540 0.545 2,477,000 0.5495
07 Jul 2021 0.565 0.570 0.555 0.560 1,256,000 0.5605
06 Jul 2021 0.560 0.580 0.560 0.565 1,514,100 0.5680
05 Jul 2021 0.575 0.575 0.555 0.560 2,265,000 0.5609
02 Jul 2021 0.585 0.585 0.570 0.580 771,100 0.5752
01 Jul 2021 0.575 0.590 0.575 0.585 819,000 0.5803
Summary
Current 2 Weeks
(19 Jul 2021 to 02 Aug 2021)
0.600 0.620 0.550 0.550 18,520,200 -
Previous 2 Weeks
(05 Jul 2021 to 16 Jul 2021)
0.575 0.620 0.550 0.590 24,418,600 -
4 Weeks from
(07 Jun 2021 to 02 Jul 2021)
0.630 0.635 0.550 0.580 40,365,500 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.